
For many years, promising Danish life science firms and imaginative biotech entrepreneurs only had a few funds to turn to when raising capital to secure their futures: Lundbeckfonden, the Novo Nordisk Foundation and Sunstone Life Science Ventures.
In 2020, life science fund Eir Ventures joined that group, and with Tuesday's launch of a new Danish-Swedish venture fund, Sound Bioventures, opportunities to secure financing have grown.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app